Aurora Cannabis Inc. (ACB) vs Anika Therapeutics, Inc. (ANIK)
A side-by-side comparison of Aurora Cannabis Inc. and Anika Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACB
Aurora Cannabis Inc.
$4.58HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
ANIK
Anika Therapeutics, Inc.
$19.73HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACB vs ANIK
growth of $100 · dividends reinvested · last 10yACB -97.3% (-30.2%/yr)ANIK -57.8% (-8.3%/yr)ANIK compounded faster over this window
Log scale — wide-divergence pair
ACB ANIK
ACB vs ANIK: by the numbers
- •ACB is the larger company ($284M vs $264M market cap).
- •Both run net losses; ANIK's is the smaller (-3.14% vs -38.13% net margin).
- •ACB grew revenue faster over the past five years (1.68% vs -2.48% CAGR).
Metrics side by side
Valuation
| Metric | ACB | ANIK |
|---|---|---|
| Forward P/E | N/A | 18.79 |
| P/S ratio | 1.36 | 2.19 |
| P/B ratio | 0.76 | 1.92 |
| EV / EBITDA | N/A | 489.09 |
| FCF yield | N/A | 0.21% |
Profitability
| Metric | ACB | ANIK |
|---|---|---|
| Gross margin | 42.62% | 62.16% |
| Operating margin | -14.55% | -4.24% |
| Net margin | -38.13% | -3.14% |
| ROE | -21.41% | -2.76% |
| ROIC | -15.69% | -3.17% |
Growth (annualized)
| Metric | ACB | ANIK |
|---|---|---|
| Revenue CAGR (5Y) | 1.68% | -2.48% |
| FCF CAGR (5Y) | N/A | -39.38% |
| Total return CAGR (5Y) | -42.83% | -13.40% |
Frequently asked
- Which has grown faster, ACB or ANIK?
- Over the past five years, ACB grew revenue faster — ACB at a 1.68% CAGR versus ANIK at -2.48%.
- How have ACB and ANIK total returns compared?
- Over the past 10 years, ACB delivered -30.23% and ANIK delivered -8.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.